Furthermore, the expression of this intestine-like TF signature could clearly be observed in multiple GEM studies of BO and OAC, and largely absent from GEM studies of squamous cell carcinoma, CRC and breast cancer (Fig. 3E). This evidence concerns the gene TF and bronchiolitis obliterans syndrome.